PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo- Expoloratory Evidence From the United States Substudy of Bravo
Abstract
Authors
C.A. Carroll M.A. Oleen-Burkey